Refined HLA-DPB1 Mismatch With Molecular Algorithms Predicts Outcomes in Hematopoietic Stem Cell Transplantation

05.20.22

Refined HLA-DPB1 Mismatch With Molecular Algorithms Predicts Outcomes in Hematopoietic Stem Cell Transplantation

by ASTCT

HuCART-19 Plus Ibrutinib Treatment in CLL

05.19.22

HuCART-19 Plus Ibrutinib Treatment in CLL

by ASTCT Science Highlights

Outcomes of Patients on Transplant Waiting Lists: Q&A with Dr. Giancarlo Fatobene

05.19.22

Outcomes of Patients on Transplant Waiting Lists: Q&A with Dr. Giancarlo Fatobene

by Andrés Gómez De León, MD

Impact of Genetic Factors at Diagnosis on HCT in Older AML Patients

05.17.22

Impact of Genetic Factors at Diagnosis on HCT in Older AML Patients

by ASTCT Science Highlights

Key differences in Immune Reconstitution Between ATLG and PTCy Treatments for Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

05.16.22

Key differences in Immune Reconstitution Between ATLG and PTCy Treatments for Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation

by ASTCT

Use of PTCy in 1Ag-MMUD-HCT as a Valid Alternative to Haploidentical-HCT: A Study From the Acute Leukemia Working Party of the EBMT

05.11.22

Use of PTCy in 1Ag-MMUD-HCT as a Valid Alternative to Haploidentical-HCT: A Study From the Acute Leukemia Working Party of the EBMT

by ASTCT

CAR-NKT cells: More of a Goldilocks or a Kangaroo?

05.02.22

CAR-NKT cells: More of a Goldilocks or a Kangaroo?

by Rahul Banerjee, MD, FACP, and Jennifer Saultz, DO

Outcomes After Second-Line Treatment for Acute Graft-Versus-Host Disease

04.28.22

Outcomes After Second-Line Treatment for Acute Graft-Versus-Host Disease

by ASTCT Science Highlights

HLA-DQ Heterodimers in HCT

04.26.22

HLA-DQ Heterodimers in HCT

by ASTCT Science Highlights

Theme picker

Thank you to our sponsors

Amgen

pharmacyclics